Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton London Docklands Riverside Hotel

Sep 19, 2018 8:00 AM - Sep 20, 2018 5:00 PM

265 Rotherhithe Street , London, SE16 5HW, United Kingdom

Global Clinical Trials Transparency Conference

Session 3: GDPR and Data Transparency Requirements

Session Chair(s)

Merete  Joergensen, MBA, MSc

Merete Joergensen, MBA, MSc

Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials

Merete-J Consulting CVR: 34920818, Denmark

How to ensure Data privacy and being Transparent at the same time gives rise to some considerations and concerns. What does this mean from a patient perspective, what are the considerations from industry trying to manoeuvre the requirements and what are the legal reality when working in this field.


David  Peloquin, JD

David Peloquin, JD

Senior Advisor, MRCT Center; Associate, Health care Group

Ropes & Gray LLP, United States

Deborah  Collyar

Patient's perspectives on Data Privacy versus Data Transparency: Deborah Collyar


Patient Advocates In Research (PAIR), United States

Anne  Cutting

GDPR and Data Transparency: An Industry Perspective’ : Anne Cutting

Director, Human Subject Research Governance

GSK, United Kingdom

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.